# Recursion news releases

- **Website:** https://www.recursion.com
- **Location:** Salt Lake City, United States
- **Releases:** 1
- **First release:** November 18, 2026
- **Most recent:** November 18, 2026
- **Categories:** Nasdaq:RXRX
- **Web page:** https://www.helpareporter.com/news-releases/recursion
- **RSS:** https://www.helpareporter.com/news-releases/recursion/rss.xml

## Releases

### [Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis](https://www.helpareporter.com/news-releases/recursion-announces-alignment-with-fda-on-registrational-phase-3-trial-2)

November 18, 2026 · Nasdaq:RXRX

REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies.
